BRIEF-Illumina Introduces Billion Cell Atlas, Genome-Wide Genetic Perturbation Dataset

AstraZeneca PLC +1.37%
Illumina, Inc. +0.59%
Merck & Co., Inc. +0.02%
Eli Lilly and Company -1.98%

AstraZeneca PLC

AZN

203.49

+1.37%

Illumina, Inc.

ILMN

127.38

+0.59%

Merck & Co., Inc.

MRK

120.87

+0.02%

Eli Lilly and Company

LLY

935.58

-1.98%

Jan 13 (Reuters) - Illumina Inc ILMN.O:

  • ILLUMINA: INTRODUCES BILLION CELL ATLAS, GENOME-WIDE GENETIC PERTURBATION DATASET

  • ILLUMINA: ALLIANCE FRAMEWORK WITH ASTRAZENECA, MERCK, & ELI LILLY LEADING AS FOUNDING PARTICIPANTS FOR BILLION CELL ATLAS


((Reuters.Briefs@thomsonreuters.com;))

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.